Cheryl Scott

Commercial biomanufacturing — whether for protein biologics or advanced therapies — is not solely about production scale. Product developers around the world need to combine modern technology platforms with efficient quality systems for regulatory compliance and long-term supply reliability. Modular facilities and single-use technologies are transforming biopharmaceutical manufacturing by enabling greater flexibility, scalability, and cost-efficiency.

Cheryl Scott, Editor in Chief, BPI. Welcome to the first of our three special print editions for 2026! These issues are made available exclusively to attendees of our main events across the year: BPI West (San Diego, 9–11 March), BPI Europe (Vienna, 27–30 April), the Biotechnology Innovation Organization’s (BIO’s) annual convention (San Diego, 22–25 June), and the BPI Conference and Exhibition at Biotech Week Boston (22–25 September). We look forward to meeting you when you pick yours up.

Asia is emerging as a pivotal region for biotechnology and healthcare innovation, offering unique opportunities for global companies to expand and thrive. In this eBook, BPI’s news editor discusses with a long-time advisor the importance of understanding cultural dynamics such as the concept of guanxi in China, which prioritizes interpersonal relationships over formal contracts.